Legislation watch

Search all years.

2018 Senate Bill 825: Impose new state reporting mandate on drug companies
Introduced by Sen. Steve Bieda (D) on February 15, 2018
To impose a new mandate on manufacturers of prescription drugs, to file detailed reports with the state on the costs associated with developing and marketing prescription drugs whose wholesale cost is more than $40 for a course of treatment. The bill would also create a state prescription drug “work group” comprised of individuals representing specified interests to recommend policies to mitigate the expense incurred by state medical welfare programs in providing drugs to beneficiaries.   Official Text and Analysis.
Referred to the Senate Health Policy Committee on February 15, 2018